Sarepta Therapeutics Inc
No standout activity across the feeds we track.
What this band has actually done: stocks scoring 0–25 beat the S&P 500 over the next three months 39.9% of the time, across 100,496 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in…
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2025-04-14 | Gilbert Ray Cisneros, Jr. · D-CA | House | Sold | $1,001 - $15,000 |
| 2023-07-14 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2023-06-13 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-04-10 | Daniel S. Goldman · D-NY | House | Sold | $15,001 - $50,000 |
| 2023-03-06 | Daniel S. Goldman · D-NY | House | Bought | $15,001 - $50,000 |
| 2023-03-06 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2023-01-31 | Daniel S. Goldman · D-NY | House | Sold | $1,001 - $15,000 |
| 2020-11-06 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2020-09-14 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
| 2020-06-10 | Gilbert Ray Cisneros, Jr. · D-CA | House | Sold | $1,001 - $15,000 |
Show the other 1
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2019-12-13 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.